PPD sales rise as CRO sector stays buoyant
PPD saw its sales rise 17 per cent in the fourth quarter, fuelled by its large Development segment.
PPD saw its sales rise 17 per cent in the fourth quarter, fuelled by its large Development segment.
The massive R&D reshuffle Roche announced last week in its pharmaceutical business will have no impact on any of the company's outsourcing activities, a company spokesperson said.
A new partnership between India's Reliance Life Sciences (RLS) and Ireland's GeneMedix will provide new contract opportunities for European contract bio-manufacturers.
French firm Valois Pharma will be providing Generex with a novel valve for its pressurised metered dose inhaler (pMDI), used for its innovative method of buccal delivery of insulin.
Italian contract manufacturer Procos has just opened a US office - a move that will allow the company to offer custom synthesis services directly to its US customers.
Therapeutic drugs can now be smoked like cigarettes thanks to a novel drug delivery device developed by new player Alexza Pharmaceuticals. The inhaled drugs hit the bloodstream much quicker than with other drug delivery techniques, so therapeutic...
A combination therapy to help smokers kick the habit has begun evaluation in Phase I pilot studies in the US. A sustained-release formulation of Cary Pharmaceutical's QuitPak has been developed with IntelGenx Technologies as an alternative smoking...
The US Food and Drug Administration (FDA) have issued Kentucky-based Omnicare with a blunt warning letter outlining the firm's quality and safety lapses at its repackaging facility in Toledo.